scholarly journals A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac®) in India

2013 ◽  
Vol 9 (1) ◽  
pp. 122-124 ◽  
Author(s):  
Prasad S. Kulkarni ◽  
Sidram K. Raut ◽  
Rajeev M. Dhere
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Surveillance Study ◽  
H1n1 Vaccine ◽  
Live Virus ◽  
Post Marketing Surveillance ◽  
Influenza A H1n1 ◽  
Post Marketing

scholarly journals Response to 2009 Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Patients and the Influence of Prior Seasonal Influenza Vaccination

PLoS ONE ◽  
2011 ◽  
Vol 6 (1) ◽  
pp. e16496 ◽  
Author(s):  
Darius Soonawala ◽  
Guus F. Rimmelzwaan ◽  
Luc B. S. Gelinck ◽  
Leo G. Visser ◽  
Frank P. Kroon
Keyword(s):  
Influenza Vaccination ◽  
Pandemic Influenza ◽  
Influenza A ◽  
Seasonal Influenza ◽  
H1n1 Vaccine ◽  
Seasonal Influenza Vaccination ◽  
Influenza A H1n1

Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy

2012 ◽  
Vol 67 (11) ◽  
pp. 683-684 ◽  
Author(s):  
Björn Pasternak ◽  
Henrik Svanström ◽  
Ditte Mølgaard-Nielsen ◽  
Tyra G. Krause ◽  
Hanne-Dorthe Emborg ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Fetal Outcomes ◽  
H1n1 Vaccine ◽  
Influenza A H1n1

Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy

2013 ◽  
Vol 57 (1) ◽  
pp. 26-27
Author(s):  
Björn Pasternak ◽  
Henrik Svanström ◽  
Ditte Mølgaard-Nielsen ◽  
Tyra G. Krause ◽  
Hanne-Dorthe Emborg ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Fetal Outcomes ◽  
H1n1 Vaccine ◽  
Influenza A H1n1

scholarly journals A comparison of live and inactivated influenza A (H1N1) virus vaccines

1983 ◽  
Vol 90 (3) ◽  
pp. 361-370 ◽  
Author(s):  
A. Clark ◽  
C. W. Potter ◽  
R. Jennings ◽  
J. P. Nicholl ◽  
A. F. Langrick ◽  
...  
Keyword(s):  
Virus Vaccine ◽  
Influenza A ◽  
H1n1 Virus ◽  
Serum Antibody ◽  
H1n1 Vaccine ◽  
Live Virus ◽  
Post Immunization ◽  
Influenza A H1n1 ◽  
B Virus ◽  
Antibody Titres

SUMMARYGroups of volunteers were immunized with one of three influenza virus vaccines, and the resistance to challenge infection with attenuated influenza A (H1N1) virus was measured 8 months later. The vaccines were aqueous subunit influenza A/USSR/77 (H1N1) vaccine, aqueous subunit influenza B/Hong Kong/73 vaccine, or attenuated influenza virus A (H1N1) vaccine. The B virus vaccine was included as a control to assess the incidence of natural A virus infection during the study period. A proportion of the B virus vaccinees had pre-existing A (H1N1) virus antibody and were used to study the immunity conferred by natural infection to the live virus challenge. The serum antibody responses were measured at 1 and 8 months after immunization. The results showed that all the vaccines induced serum HI antibody in a proportion of the volunteers; however, after 1 month, higher titres of serum antibody were found in volunteers given inactivated A vaccine than in those given live attenuated A virus vaccine. Eight months post-immunization the titres of serum antibody in volunteers given inactivated vaccine had declined significantly, but there were no changes in the antibody titres of those given live virus vaccine. The incidence of infection by the challenge virus at 8 months post-immunization was directly related to the serum antibody titres 1 month post-immunization; no evidence was obtained to suggest that those given live virus vaccine had a more solid immunity than those given inactivated vaccine.

scholarly journals Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy

JAMA ◽  
2012 ◽  
Vol 308 (2) ◽  
Author(s):  
Björn Pasternak ◽  
Henrik Svanström ◽  
Ditte Mølgaard-Nielsen ◽  
Tyra G. Krause ◽  
Hanne-Dorthe Emborg ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Fetal Outcomes ◽  
H1n1 Vaccine ◽  
Influenza A H1n1

scholarly journals Two doses of pandemic influenza A(H1N1) vaccine: Tolerability in healthy young children in the Netherlands

2011 ◽  
Vol 7 (10) ◽  
pp. 1048-1054 ◽  
Author(s):  
Tessa M. van ’t Klooster ◽  
Jeanet M. Kemmeren ◽  
Hester E. de Melker ◽  
Patricia E. Vermeer-de Bondt ◽  
Nicoline A.T. van der Maas
Keyword(s):  
Young Children ◽  
The Netherlands ◽  
Pandemic Influenza ◽  
Influenza A ◽  
H1n1 Vaccine ◽  
Influenza A H1n1
Sign in / Sign up

Export Citation Format

Share Document